Epidemiology of Subacute Sclerosing Panencephalitis (SSPE) in Germany from 2003 to 2009: A Risk Estimation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Schönberger, Katharina ^a,d   Ludwig, Maria Sabine ^b   Wildner, Manfred ^a   Weissbrich, Benedikt ^c  

^a Bavarian Health and Food Safety Authority   (Germany)

^b Bavarian Health and Food Safety Authority   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ACUTE DISEASE; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; FATALITY; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; INFANT; INFECTION PREVENTION; MALE; MEASLES; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; GERMANY; HISTORY, 21ST CENTURY; HUMANS; MALE; MEASLES; RISK; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 84879948774     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068909     Document Type: Article

References (18)

1. Campbell H, Andrews N, Brown KE, Miller E, (2007) Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 36: 1334-1348.
2. Garg RK, (2008) Subacute sclerosing panencephalitis. J Neurol 255: 1861-1871.
3. Gutierrez J, Issacson RS, Koppel BS, (2010) Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol 52: 901-907.
4. Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, et al. (2005) Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 192: 1686-1693.
5. Weissbrich B, Schneider-Schaulies J, ter Meulen V (2003) Measles and its neurological complications. In: Nath A, Berger JR, editors. Clinical Neurovirology. New York: Dekker. 401-430.
6. Campbell C, Levin S, Humphreys P, Walop W, Brannan R, (2005) Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature. BMC Pediatr 5: 47.
7. Rima BK, Duprex WP, (2005) Molecular mechanisms of measles virus persistence. Virus Res 111: 132-147.
8. Reuter D, Schneider-Schaulies J, (2010) Measles virus infection of the CNS: human disease, animal models, and approaches to therapy. Med Microbiol Immunol 199: 261-271.
9. Modlin JF, Jabbour JT, Witte JJ, Halsey NA, (1977) Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics 59: 505-512.
10. Miller C, Farrington CP, Harbert K, (1992) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol 21: 998-1006.
11. Miller C, Andrews N, Rush M, Munro H, Jin L, et al. (2004) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Arch Dis Child 89: 1145-1148.
12. Gobel U, Heinrich B, Krauth KA, Steingruber HJ, von Kries R, (2010) [Process and outcome quality of the German Paediatric Surveillance Unit (ESPED)]. Klin Padiatr 222: 92-97.
13. LaPorte RE, McCarty DJ, Tull ES, Tajima N, (1992) Counting birds, bees, and NCDs. Lancet 339: 494-495.
14. Ruckinger S, Boneberger A, (2008) [Epidemiologic challenges in rare diseases]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51: 483-490.
15. Hook EB, Regal RR, (1995) Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev 17: 243-264.
16. Gascon GG, (1996) Subacute sclerosing panencephalitis. Semin Pediatr Neurol 3: 260-269.
17. Mette A, Reuss AM, Feig M, Kappelmayer L, Siedler A, et al. (2011) Under-reporting of measles: an evaluation based on data from north rhine-westphalia. Dtsch Arztebl Int 108: 191-196.
18. Halsey NA, Modlin JF, Jabbour JT, Dubey L, Eddins DL, et al. (1980) Risk factors in subacute sclerosing panencephalitis: a case-control study. Am J Epidemiol 111: 415-424.